![A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo | Journal of Virology A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo | Journal of Virology](https://journals.asm.org/cms/10.1128/JVI.01126-21/asset/c5fa1d87-be70-44d9-8e57-33acec751cf2/assets/images/large/jvi.01126-21-f001.jpg)
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo | Journal of Virology
![Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development](https://www.mdpi.com/vaccines/vaccines-09-01052/article_deploy/html/images/vaccines-09-01052-g001.png)
Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
![Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia - Chan - 2021 - Annals of the New York Academy of Sciences - Wiley Online Library Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia - Chan - 2021 - Annals of the New York Academy of Sciences - Wiley Online Library](https://nyaspubs.onlinelibrary.wiley.com/cms/asset/a73a9177-e389-4dc3-a4fd-268357710fae/nyas14562-gra-0001-m.jpg?trick=1668960718486)
Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia - Chan - 2021 - Annals of the New York Academy of Sciences - Wiley Online Library
![Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers](https://www.mdpi.com/diagnostics/diagnostics-12-00205/article_deploy/html/images/diagnostics-12-00205-g001.png)
Diagnostics | Free Full-Text | Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers
![Viruses | Free Full-Text | Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages Viruses | Free Full-Text | Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages](https://pub.mdpi-res.com/viruses/viruses-14-02764/article_deploy/html/images/viruses-14-02764-g001.png?1670827269)
Viruses | Free Full-Text | Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages
![Pharmaceuticals | Free Full-Text | Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants Pharmaceuticals | Free Full-Text | Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-01002/article_deploy/html/images/pharmaceuticals-15-01002-ag.png?1660556681)
Pharmaceuticals | Free Full-Text | Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants
![Vaccines | Free Full-Text | Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors Vaccines | Free Full-Text | Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors](https://pub.mdpi-res.com/vaccines/vaccines-10-01437/article_deploy/html/images/vaccines-10-01437-g001.png?1661947662)
Vaccines | Free Full-Text | Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors
![Viruses | Free Full-Text | Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy Viruses | Free Full-Text | Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy](https://www.mdpi.com/viruses/viruses-13-01356/article_deploy/html/images/viruses-13-01356-g001.png)
Viruses | Free Full-Text | Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy
![Biomolecules | Free Full-Text | Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2 Biomolecules | Free Full-Text | Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2](https://pub.mdpi-res.com/biomolecules/biomolecules-12-00572/article_deploy/html/images/biomolecules-12-00572-g003.png?1649837638)
Biomolecules | Free Full-Text | Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2
![Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants](https://www.mdpi.com/viruses/viruses-14-01332/article_deploy/html/images/viruses-14-01332-g001.png)
Viruses | Free Full-Text | Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
![Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein](https://www.mdpi.com/viruses/viruses-13-01974/article_deploy/html/images/viruses-13-01974-g002.png)
Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
![Pharmaceuticals | Free Full-Text | Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo Pharmaceuticals | Free Full-Text | Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00021/article_deploy/html/images/pharmaceuticals-15-00021-g001.png?1640344272)
Pharmaceuticals | Free Full-Text | Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
Singular Interface Dynamics of the SARS-CoV-2 Delta Variant Explained with Contact Perturbation Analysis | Journal of Chemical Information and Modeling
![Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein](https://www.mdpi.com/viruses/viruses-13-01974/article_deploy/html/images/viruses-13-01974-g001.png)
Viruses | Free Full-Text | Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
![Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants](https://www.mdpi.com/vaccines/vaccines-09-01409/article_deploy/html/images/vaccines-09-01409-g001.png)
Vaccines | Free Full-Text | VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
![Diagnostics | Free Full-Text | Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs Diagnostics | Free Full-Text | Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs](https://www.mdpi.com/diagnostics/diagnostics-11-01190/article_deploy/html/images/diagnostics-11-01190-g005.png)
Diagnostics | Free Full-Text | Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs
![The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape | medRxiv The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/07/25/2021.02.23.21252268/F1.large.jpg)